Standout Papers

Irinotecan plus Fluorouracil and Leucovorin for Metastatic Colorectal Cancer 2000 2026 2008 2017 2.3k
  1. Irinotecan plus Fluorouracil and Leucovorin for Metastatic Colorectal Cancer (2000)
    Leonard B. Saltz, John V. Cox et al. New England Journal of Medicine
  2. Comparison of Oral Capecitabine Versus Intravenous Fluorouracil Plus Leucovorin as First-Line Treatment in 605 Patients With Metastatic Colorectal Cancer: Results of a Randomized Phase III Study (2001)
    Paulo M. Hoff, Rafat Ansari et al. Journal of Clinical Oncology

Immediate Impact

2 by Nobel laureates 3 from Science/Nature 111 standout
Sub-graph 1 of 14

Citing Papers

Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries
2021 Standout
CDX2 as a Prognostic Biomarker in Stage II and Stage III Colon Cancer
2016 Standout
3 intermediate papers

Works of John V. Cox being referenced

Irinotecan plus Fluorouracil and Leucovorin for Metastatic Colorectal Cancer
2000 Standout
Irinotecan Hydrochloride (CPT-11) Resistance Identified by K-ras Mutation in Patients with Progressive Colon Cancer After Treatment with 5-Fluorouracil (5-FU)
1997
and 1 more

Author Peers

Author Last Decade Papers Cites
John V. Cox 3342 183 124 1061 1040 65 4.2k
G. Ganem 3223 119 125 976 1124 67 4.4k
Claus‐Henning Köhne 3069 113 203 1082 1173 73 4.2k
Valérie Jooste 2281 130 97 480 967 115 4.5k
D. Papamichael 2989 55 30 904 935 26 3.6k
Sheryl Koski 3545 128 51 1111 1400 35 4.7k
Félix Couture 2649 88 39 934 1109 45 3.2k
Bruce J. Giantonio 3309 131 60 946 1541 123 4.9k
N Le Bail 4669 59 20 1477 1364 23 5.4k
Isabelle Tabah-Fisch 3614 91 172 490 1011 23 4.5k
Philip R. Clingan 4616 92 35 607 1408 45 5.5k

All Works

Loading papers...

Rankless by CCL
2026